Search

Your search keyword '"Rizzo, J. Douglas"' showing total 15 results
Start Over Author "Rizzo, J. Douglas" Journal transplantation and cellular therapy
15 results on '"Rizzo, J. Douglas"'

1. Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018

Author

Valcarcel, Bryan, Schonfeld, Sara J., Meyer, Christa L., Brunson, Ann, Cooley, Julianne J.P., Abrahão, Renata, Wun, Ted, Auletta, Jeffery J., Gadalla, Shahinaz M., Engels, Eric, Albert, Paul S., Spellman, Stephen R., Rizzo, J. Douglas, Shaw, Bronwen E., Muffly, Lori, Keegan, Theresa H.M., and Morton, Lindsay M.

Published
2024
Full Text
View/download PDF

2. Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018

Author

Valcarcel, Bryan, primary, Schonfeld, Sara J., additional, Meyer, Christa L., additional, Brunson, Ann, additional, Cooley, Julianne J.P., additional, Abrahão, Renata, additional, Wun, Ted, additional, Auletta, Jeffery J., additional, Gadalla, Shahinaz M., additional, Engels, Eric, additional, Albert, Paul S., additional, Spellman, Stephen R., additional, Rizzo, J. Douglas, additional, Shaw, Bronwen E., additional, Muffly, Lori, additional, Keegan, Theresa H.M., additional, and Morton, Lindsay M., additional

Published
2023
Full Text
View/download PDF

3. Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

Author

Auletta, Jeffery J., Kou, Jianqun, Chen, Min, Bolon, Yung-Tsi, Broglie, Larisa, Bupp, Caitrin, Christianson, Debra, Cusatis, Rachel N., Devine, Steven M., Eapen, Mary, Hamadani, Mehdi, Hengen, Mary, Lee, Stephanie J., Moskop, Amy, Page, Kristin M., Pasquini, Marcelo C., Perez, Waleska S., Phelan, Rachel, Riches, Marcie L., Rizzo, J. Douglas, Saber, Wael, Spellman, Stephen R., Stefanski, Heather E., Steinert, Patricia, Tuschl, Eileen, Yusuf, Rafeek, Zhang, Mei-Jie, and Shaw, Bronwen E.

Published
2023
Full Text
View/download PDF

4. Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry

Author

Cusatis, Rachel, Flynn, Kathryn E., Vasu, Sumithira, Pidala, Joseph, Muffly, Lori, Uberti, Joseph, Tamari, Roni, Mattila, Deborah, Mussetter, Alisha, Bruzauskas, Ruta, Chen, Min, Leckrone, Erin, Myers, Judith, Mau, Lih-Wen, Rizzo, J Douglas, Saber, Wael, Horowitz, Mary, Lee, Stephanie J., Burns, Linda J, and Shaw, Bronwen

Published
2022
Full Text
View/download PDF

5. Impact of Public Reporting of Center-Specific Analysis Scores on Hematopoietic Cell Transplant Center Volumes

Author

Sharma, Akshay, primary, Logan, Brent, additional, Estrada-Merly, Noel, additional, Lehmann, Leslie E., additional, Rangarajan, Hemalatha G., additional, Preussler, Jaime M., additional, Troy, Jesse D, additional, Akard, Luke P, additional, Bhatt, Neel S., additional, Truong, Tony H, additional, Wood, William, additional, Rizzo, J. Douglas, additional, and Saber, Wael, additional

Published
2023
Full Text
View/download PDF

6. Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report from the BMT CTN Patient and Caregiver Advocacy Task Force

Author

Vasu, Sumithira, primary, Holtan, Shernan Grace, additional, Shimamura, Akiko, additional, Burnworth, Todd, additional, Whisenton, Shauna, additional, Adams, Sanderson, additional, Nuechterlein, Brandon, additional, Mortier, Nicole, additional, Foster, Jackie, additional, DiFronzo, Nancy, additional, Horowitz, Mary M., additional, Rizzo, J. Douglas, additional, and Foley, Amy, additional

Published
2023
Full Text
View/download PDF

7. Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]

Author

D'Souza, Anita, primary, Fretham, Caitrin, additional, Lee, Stephanie J., additional, Arora, Mukta, additional, Brunner, Janet, additional, Chhabra, Saurabh, additional, Devine, Steven, additional, Eapen, Mary, additional, Hamadani, Mehdi, additional, Hari, Parameswaran, additional, Pasquini, Marcelo C., additional, Perez, Waleska, additional, Phelan, Rachel A., additional, Riches, Marcie L., additional, Rizzo, J. Douglas, additional, Saber, Wael, additional, Shaw, Bronwen E., additional, Spellman, Stephen R., additional, Steinert, Patricia, additional, Weisdorf, Daniel J., additional, and Horowitz, Mary M., additional

Published
2022
Full Text
View/download PDF

8. Corrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]

Author

Chhabra, Saurabh, primary, Visotcky, Alexis, additional, Pasquini, Marcelo C., additional, Zhu, Fenlu, additional, Tang, Xiaoying, additional, Zhang, Mei-Jie, additional, Thompson, Robert, additional, Abedin, Sameem, additional, D'Souza, Anita, additional, Dhakal, Binod, additional, Drobyski, William R., additional, Fenske, Timothy S., additional, Jerkins, James H., additional, Rizzo, J. Douglas, additional, Runaas, Lyndsey, additional, Saber, Wael, additional, Shah, Nirav N., additional, Shaw, Bronwen E., additional, Horowitz, Mary M., additional, Hari, Parameswaran N., additional, and Hamadani, Mehdi, additional

Published
2022
Full Text
View/download PDF

10. COVID-19 and Hematopoietic Cell Transplant Center-specific survival analysis: Can we adjust for the impact of the pandemic? Recommendations of the COVID-19 Taskforce of the 2020 CIBMTR Center Outcomes Forum

Author

Wingard, John R., Ahn, Kwang Woo, Dandoy, Christopher, Perales, Miguel-Angel, Wood, William A., Logan, Brent, Riches, Marcie, and Rizzo, J. Douglas

Subjects
Bone Marrow, SARS-CoV-2, Hematopoietic Stem Cell Transplantation, COVID-19, Humans, Pandemics, Article
Abstract

COVID-19 has significantly impacted the practice of hematopoietic cell transplantation (HCT) and likely affected outcomes of HCT recipients. Early reports document substantially higher case fatality rates for HCT recipients than faced by the general population. The threat to individual patients is real, but at present, we do not have a clear picture of how much of this threat is present within the first year after HCT, as the majority of cases in early reports occurred after the first year. Still unknown is how infection rates and outcomes vary with time after HCT. This is important because center-specific survival estimates for reporting purposes focus on 1-year post-HCT mortality. Transplant centers have dramatically changed practices due to the pandemic. For many centers, quality assurance processes and procedures were disrupted, and these changes likely affected team performance. Centers have been affected unevenly by the pandemic, by time, location, and COVID-19 burden. Assessment of center-specific survival depends on the ability to adjust for risk factors such as COVID-19 that are outside center control using consistent methods so that team performance based on controllable risk factors can be ascertained. The Center of International Blood and Marrow Transplantation Research (CIBMTR) convened a working group for the 2020 Center Outcomes Forum (COF) to assess the impact of COVID-19 on both patient-specific risks and center-specific performance. This committee reviewed the factors at play and developed recommendations for a process to determine if adjustments in the methodology to assess center-specific performance are needed.

Published
2021

13. In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy

Author

Dandoy, Christopher E, Adams, Joan, Artz, Andrew, Bredeson, Christopher, Dahi, Parastoo B, Dodd, Therese, Jaglowski, Samantha, Lehmann, Leslie, LeMaistre, Charles F, Mian, Amir, Neal, Alison, Page, Kristen, Rizzo, J. Douglas, Rotz, Seth, Sorror, Mohamed, Steinberg, Amir, Viswabandya, Auro, and Howard, Dianna S

Abstract

Immune Effector Cell (IEC) therapy represents a transformative advancement in oncology, leveraging the immune system to combat various malignancies. This manuscript outlines a comprehensive framework for establishing and maintaining quality standards in IEC therapy amidst rapid scientific and clinical advancements. We emphasize the integration of structured process measures, robust quality assurance, and meticulous outcome evaluation to ensure treatment efficacy and safety. Key components include multidisciplinary expertise, stringent accreditation protocols, and advanced data management systems, which facilitate standardized reporting and continual innovation. The collaborative effort among stakeholders—ranging from patients and healthcare providers to regulatory bodies—is crucial in delivering high-quality IEC therapies. This framework aims to enhance patient outcomes and cement the role of IEC therapy as a cornerstone of modern oncology, promoting continuous improvement and adherence to high standards across the therapeutic spectrum.

Published
2024
Full Text
View/download PDF

14. Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]

Author

D'Souza, Anita, Fretham, Caitrin, Lee, Stephanie J., Arora, Mukta, Brunner, Janet, Chhabra, Saurabh, Devine, Steven, Eapen, Mary, Hamadani, Mehdi, Hari, Parameswaran, Pasquini, Marcelo C., Perez, Waleska, Phelan, Rachel A., Riches, Marcie L., Rizzo, J. Douglas, Saber, Wael, Shaw, Bronwen E., Spellman, Stephen R., Steinert, Patricia, Weisdorf, Daniel J., and Horowitz, Mary M.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results